Wall Street Journal Examines Debate Over Use Of Antipsychotics To Calm Symptoms Of Dementia Patients
Main Category: Alzheimer's / DementiaAlso Included In: Psychology / Psychiatry
Article Date: 21 Dec 2007 - 6:00 PDT
| Patient / Public: | ![]() |
5 (4 votes) |
| Healthcare Prof: | ![]() |
4.43 (7 votes) |
| Article Opinions: | 1 posts |
The Wall Street Journal on Thursday examined how the "challenge of caring for rising numbers of seniors who suffer from dementia and the behavior problems that can stem from it has provoked a wrenching debate" over the use of atypical antipsychotics to calm symptoms in such patients.
Federal law discourages the use of physical restraints on dementia patients, but federal programs such as Medicaid cover the cost of medications used to calm symptoms in such patients. In 2005, Medicaid spent $5.4 billion on atypical antipsychotics, more than any other class of medications. Labels for atypical antipsychotics include a "black box" warning about increased risk for death among elderly dementia patients.
Last year, CMS implemented new rules to limit the use of antipsychotics, but currently "it's still easier for nursing homes to get reimbursed for giving patients extra pills than it is for hiring more staff" to care for dementia patients.
Cynthia Rudder of the Long-Term Care Community Coalition said that nursing home employees "are basically quieting" dementia patients "against their will," adding that "it is absolutely horrendous." Larry Minnix, president of the American Association of Homes and Services for the Aging, said, "We cannot treat people by simply throwing antipsychotic drugs at them for our convenience."
Senate Finance Committee ranking member Chuck Grassley (R-Iowa) earlier this month asked several pharmaceutical companies to provide documents about efforts to market the medications directly or indirectly for use in nursing home patients.
According to Dennis Smith, director of the Center for Medicaid and State Operations at CMS, nursing homes should seek a "different model" of care to ensure that "unlocking the drug cabinet" is not their only response to the symptoms of dementia patients. CMS also seeks to offer nursing homes alternatives and inform them that they "will be open to scrutiny," Smith said (Lagnado, Wall Street Journal, 12/10).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our alzheimer's / dementia section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/92505.php>
APA
http://www.medicalnewstoday.com/releases/92505.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Antipsychotic Drugs Useful For PATIENTS
posted by anon on 25 Dec 2007 at 3:11 pmI am the director of a secured alzheimer's unit. We NEVER medicate our residents for the convenience of our staff... We have a small unit and know our residents well. All our staff has special training related to Alzheimer's disease.
I have seen that antipsychotic medications can be very helpful to those with dementia. Often these folks suffer with paranoia, delusions and sometimes hallucinations. How miserable to think others are trying to harm you and to be upset and anxious. I have seen folks who are able to go from this state, to being able to enjoy themselves and experience a much higher quality of life with the right medication.
Sedation is certainly not the goal, but mediation combined with staff who are trained in how to deal with these behaviors and issues is often the best combination. Even though about 43% of our residents take an antipsychotic, many are on much lower doses than when they were at home, either alone or with family. It is very discouraging to get people stablized only to be told by the state, feds and owning company that we must reduce these medications, thus sending the resident back into the original state of anxiety/paranoia. I believe that taking away or withholding medication is as abusive as giving medication to sedate.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.






